Validation of the Efficacy and Usability of the BELK Orthosis Knee Module in a Neurological Setting (BELK@CCP) (BELK@CCP)
Knee Instability, Neuromuscular Diseases, Central Nervous System Diseases
About this trial
This is an interventional treatment trial for Knee Instability
Eligibility Criteria
Inclusion Criteria:
- Age: 30 - 85
- Sex: males and females
- Diagnosis of Neuromuscular diseases (NMD) or central nervous system (CNS) disorder with knee instability conditioning gait
- Functional Ambulation Categories (FAC) > 3
- Mini Mental State Examination (MMSE) > 24
- Ability to walk at least 10 meters alone or with maximum 1 person assistance
Exclusion Criteria:
- Bilateral impairment of the knees
- Knee implant
- Lower extremity amputation
- Severe sensorial impairment of the lower limbs
- Legal blindness or severe visual impairment
- Pacemakers or metal implants
- Refusal to give informed consent
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
With knee exoskeleton
Without exoskeleton
The rehabilitation training will be focused on lower limb with specific activities for knee instability, and will concern both physical training (e.g., locomotion task, balance exercise, muscle reinforcement, proprioceptive task) and occupational treatment tasks (e.g., transferring/mobility, meal preparation, house-working). Each session will be 45 minutes long. Three time per week, for three weeks. The patients allocated in this arm will perform the training wearing the BELK device.
The rehabilitation training will be focused on lower limb with specific activities for knee instability, and will concern both physical training (e.g., locomotion task, balance exercise, muscle reinforcement, proprioceptive task) and occupational treatment tasks (e.g., transferring/mobility, meal preparation, house-working). Each session will be 45 minutes long. Three time per week, for three weeks. The patients allocated in this arm will perform the training without any exoskeleton.